By Regulatory Approvals — Recon: FDA approves treatments for prostate cancer, Crohn’s disease; US judge refuses to halt Lilly weight-loss drug ads RAPS
Read the original at Regulatory Approvals ↗
Auto-published by the finit.news Events monitor from Regulatory Approvals; summarized by AI and may contain errors — verify against the primary source. October 27, 2026.